TY - JOUR
T1 - Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease
AU - McDermott, Mary M.
AU - Guralnik, Jack M.
AU - Tian, Lu
AU - Zhao, Lihui
AU - Polonsky, Tamar S.
AU - Kibbe, Melina R.
AU - Criqui, Michael H.
AU - Zhang, Dongxue
AU - Conte, Michael S.
AU - Domanchuk, Kathryn
AU - Li, Lingyu
AU - Sufit, Robert
AU - Leeuwenburgh, Christiaan
AU - Ferrucci, Luigi
N1 - Publisher Copyright:
© 2019 Society for Vascular Surgery
PY - 2020/3
Y1 - 2020/3
N2 - Background: Randomized trials of people with peripheral artery disease (PAD) and intermittent claudication have traditionally used maximal treadmill walking distance as the primary outcome, but the 6-minute walk test is increasingly used as a primary outcome in randomized trials of PAD. This study compared relative changes in maximal treadmill walking distance versus 6-minute walk distance in response to a therapeutic intervention or control in randomized trials of participants with PAD. Methods: Data from four randomized trials of therapeutic interventions in participants with PAD that measured both 6-minute walk and treadmill walking performance at baseline and the 6-month follow-up were combined. Two trials studied supervised treadmill exercise, one studied home-based walking exercise, and one studied resveratrol. Results: Of 467 participants (mean age, 69.8; standard deviation, 9.7), the mean ankle-brachial index was 0.66 (standard deviation, 0.17). At the 6-month follow-up, participants with PAD randomized to control or placebo significantly declined in 6-minute walk distance (−10.2 m; 95% confidence interval, −18.2 to −2.2; P =.013), but improved maximal treadmill walking distance (+25.7 m; 95% CI, +6.0 to +45.3 m; P =.010; difference between change in 6-minute walk versus maximal treadmill walking distance: −37.3 m; 95% CI, −56.4 to −18.2; P <.001). Home-based exercise improved the 6-minute walk distance by 43.2 m (95% CI, +28.4 to +57.9), and supervised treadmill exercise improved the 6-minute walk distance by 25.0 m (95% CI, +14.7 to +35.2; mean difference, +18.2 m favoring home-based exercise [95% CI, +0.2 to +36.2 m; P =.048]). Among all participants, the presence (vs absence) of treadmill exercise training was associated with a 141.3-m greater improvement in maximal treadmill walking distance compared to 6-minute walk distance (95% CI, 88.2-194.4; P <.001), suggesting a benefit from treadmill training on the treadmill outcome. Conclusions: Maximal treadmill walking distance and the 6-minute walk distance are not interchangeable outcomes in participants with PAD. Participants with PAD randomized to control groups improved treadmill walking distance but simultaneously meaningfully declined in 6-minute walk distance. Supervised treadmill exercise training amplified improvement in treadmill walking distance because of a training to the outcome measure phenomenon.
AB - Background: Randomized trials of people with peripheral artery disease (PAD) and intermittent claudication have traditionally used maximal treadmill walking distance as the primary outcome, but the 6-minute walk test is increasingly used as a primary outcome in randomized trials of PAD. This study compared relative changes in maximal treadmill walking distance versus 6-minute walk distance in response to a therapeutic intervention or control in randomized trials of participants with PAD. Methods: Data from four randomized trials of therapeutic interventions in participants with PAD that measured both 6-minute walk and treadmill walking performance at baseline and the 6-month follow-up were combined. Two trials studied supervised treadmill exercise, one studied home-based walking exercise, and one studied resveratrol. Results: Of 467 participants (mean age, 69.8; standard deviation, 9.7), the mean ankle-brachial index was 0.66 (standard deviation, 0.17). At the 6-month follow-up, participants with PAD randomized to control or placebo significantly declined in 6-minute walk distance (−10.2 m; 95% confidence interval, −18.2 to −2.2; P =.013), but improved maximal treadmill walking distance (+25.7 m; 95% CI, +6.0 to +45.3 m; P =.010; difference between change in 6-minute walk versus maximal treadmill walking distance: −37.3 m; 95% CI, −56.4 to −18.2; P <.001). Home-based exercise improved the 6-minute walk distance by 43.2 m (95% CI, +28.4 to +57.9), and supervised treadmill exercise improved the 6-minute walk distance by 25.0 m (95% CI, +14.7 to +35.2; mean difference, +18.2 m favoring home-based exercise [95% CI, +0.2 to +36.2 m; P =.048]). Among all participants, the presence (vs absence) of treadmill exercise training was associated with a 141.3-m greater improvement in maximal treadmill walking distance compared to 6-minute walk distance (95% CI, 88.2-194.4; P <.001), suggesting a benefit from treadmill training on the treadmill outcome. Conclusions: Maximal treadmill walking distance and the 6-minute walk distance are not interchangeable outcomes in participants with PAD. Participants with PAD randomized to control groups improved treadmill walking distance but simultaneously meaningfully declined in 6-minute walk distance. Supervised treadmill exercise training amplified improvement in treadmill walking distance because of a training to the outcome measure phenomenon.
KW - 6-Minute walk
KW - Clinical trials
KW - Disability
KW - Functional status
KW - Peripheral artery disease
UR - http://www.scopus.com/inward/record.url?scp=85076859613&partnerID=8YFLogxK
U2 - 10.1016/j.jvs.2019.05.058
DO - 10.1016/j.jvs.2019.05.058
M3 - Article
C2 - 31870756
AN - SCOPUS:85076859613
SN - 0741-5214
VL - 71
SP - 988
EP - 1001
JO - Journal of Vascular Surgery
JF - Journal of Vascular Surgery
IS - 3
ER -